blog

Discover translational pharmacology strategies from industry expert to improve target validation, PK/PD understanding, and animal-to-human translation in early-phase drug development.

Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.

Discover how clinic-ready manufacturing and adaptive clinical trials streamline drug development, prevent delays, conserve your resources, and ensure safety, compliance, and efficiency.

The 2025 Year in Review highlights 30 years of drug development expertise, key milestones, events, resources, and innovations shaping early-phase research.

Altasciences conducted two drug-drug interaction studies to evaluate a novel cardiovascular therapy’s safety with clopidogrel and warfarin, ensuring safe co-administration.

Research Laboratory Technician Josiah Liang opens up about how clinical research has profoundly impacted his life and shaped his career in the field.

Beatrice Setnik, PhD, discusses the mission of CCALC, the importance of abuse potential studies, and challenges in evaluating psychedelics for clinical use.